Ryan Stewart, DO
Board-certified and fellowship-trained urogynecologist
Green Bay, Wisconsin
✓ Medically reviewed September 3, 2026
No financial ties to any device or drug maker

Vaginal estrogen

Vaginal estrogen is the first-line hormonal treatment for genitourinary syndrome of menopause (GSM), the cluster of vaginal, urinary, and sexual symptoms that follow the drop in estrogen around and after menopause. It is a low dose of hormone placed directly in the vagina, and for most women it is the single most effective way to reverse the tissue changes behind dryness, irritation, and painful sex. This page is a broad overview. The topics linked at the end go deeper on safety, formulation choice, and specific situations.

What GSM is

Genitourinary syndrome of menopause describes the range of symptoms and physical changes that result from declining estrogen and androgen in the genitourinary tract during and after the menopausal transition. You may also see the older term vaginal atrophy. The vagina, vulva, urethra, and bladder all respond to estrogen, so when estrogen falls these tissues become thinner, drier, and less elastic. It is common, affecting an estimated 27 to 84 percent of postmenopausal women, though many never bring it up with a clinician. Unlike hot flashes, which tend to ease over time, GSM is chronic and progressive and usually does not get better on its own.

What it treats

The evidence is strongest for the classic vulvovaginal symptoms. Guidelines give a strong recommendation for local low-dose vaginal estrogen to improve vulvovaginal discomfort or irritation, dryness, and pain with sex. Restoring estrogen locally rehydrates and thickens the tissue and makes intercourse comfortable again for most women. It does more than mask symptoms, because it treats the underlying tissue change, which is why the improvement holds as long as you keep using it.

Vaginal estrogen also lowers the risk of recurrent urinary tract infections. This use actually carries the highest grade of evidence in the current GSM guideline, higher than any other single indication. By restoring a healthier vaginal environment, it makes the tissue less hospitable to the bacteria that drive repeat infections. It may also ease some urinary and overactive-bladder symptoms such as urgency and frequency, though that evidence is more modest.

Local therapy, not systemic hormones

The most important thing to understand is that vaginal estrogen works locally. At the low doses used for GSM, very little estrogen reaches the bloodstream, and blood estrogen levels stay within the normal postmenopausal range. That is what sets it apart from systemic hormone therapy, the pills or patches used mainly for hot flashes, which raise estrogen throughout the body. For GSM alone, low-dose vaginal estrogen is considered the criterion standard treatment. Systemic therapy is a separate decision with its own risks and benefits, and it is not the right tool for GSM by itself. It can even worsen urinary leakage, whereas local vaginal estrogen tends to improve it.

The forms it comes in

Vaginal estrogen comes as a cream, a small vaginal tablet or insert, and a ring that sits in the vagina and is changed every few months. At the doses used for GSM, guidelines find no clinically meaningful difference in how well these forms work, so the choice comes down to preference and what fits your life. Some women like the flexibility of a cream, some prefer the tidiness of a fixed-dose insert, and others prefer a ring they can leave in place for months. Patient preference, ease of application, and cost all reasonably guide the decision.

Is it safe?

Yes. Because systemic absorption is minimal, low-dose vaginal estrogen does not require an added progestogen and does not call for routine monitoring of the uterine lining, even in women who still have a uterus. This surprises people, because systemic estrogen does require progestogen protection of the uterus. Guidelines are clear that local low-dose vaginal estrogen does not raise the risk of endometrial cancer. Any new bleeding after menopause still needs to be evaluated on its own, whether or not you use vaginal estrogen.

How long it takes, and how long to stay on it

Give it time. Symptoms usually begin to improve within a few weeks, and full benefit can take about twelve weeks. Because GSM is a chronic, progressive condition, vaginal estrogen is ongoing therapy rather than a short course. Symptoms tend to return within a few months of stopping, so most women who benefit stay on it, with periodic follow-up, for as long as the symptoms would otherwise trouble them.

How I approach it

GSM is one of the more satisfying problems I treat, because low-dose vaginal estrogen so reliably helps and the safety picture is reassuring once the local-versus-systemic distinction is clear. I spend much of the visit on that distinction and on matching the form to how a woman actually wants to use it, because the best option is the one she will keep using.

Where to go deeper

The other pages in this section cover the details: how safe vaginal estrogen really is and what the old boxed warning means, using it after breast cancer, choosing between the cream, ring, and tablet, its role in preventing recurrent UTIs, how to apply it correctly, and the nonhormonal and alternative options for women who would rather avoid estrogen or cannot use it.

References

Kaufman MR, Ackerman AL, Amin KA, et al. Genitourinary Syndrome of Menopause: AUA/SUFU/AUGS Guideline. American Urological Association. 2025.
Faubion SS, Kingsberg SA, Clark AL, et al. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020. doi:10.1097/GME.0000000000001609
Faubion SS, Sood R, Kapoor E. Genitourinary Syndrome of Menopause: Management Strategies for the Clinician. Mayo Clinic Proceedings. 2017. doi:10.1016/j.mayocp.2017.08.019
Rahn DD, Carberry C, Sanses TV, et al. Vaginal Estrogen for Genitourinary Syndrome of Menopause: A Systematic Review. Obstetrics & Gynecology. 2014. doi:10.1097/AOG.0000000000000526
Ringel NE, Iglesia C. Common Benign Chronic Vulvar Disorders. American Family Physician. 2020.

Frequently Asked Questions

What does vaginal estrogen cream do?

Vaginal estrogen cream delivers a low dose of estrogen directly to the vaginal tissue, where it reverses the thinning and dryness of genitourinary syndrome of menopause and relieves vaginal dryness, discomfort or irritation, and pain with sex. In women with recurrent urinary tract infections, it also lowers the risk of future infections.

What is Estrace cream used for?

Estrace is a brand of estradiol vaginal cream, one of the low-dose vaginal estrogens approved for genitourinary syndrome of menopause. It treats the vaginal dryness, irritation, and painful sex that follow the drop in estrogen after menopause.

What is Premarin cream used for?

Premarin vaginal cream is a conjugated estrogen cream, a form of low-dose vaginal estrogen approved for genitourinary syndrome of menopause. Like other vaginal estrogens, it treats menopausal vaginal dryness, irritation, and painful sex.